| AI | Artificial intelligence |
| ASCO | American Association of Clinical Oncology |
| ATOM | Accelerating Therapeutics for Opportunities in Medicine |
| AUC | Area under the curve |
| CADe | Computer-aided detection |
| CADx | Computer-aided diagnosis |
| CANDLE | Cancer Distributed Learning Environment |
| CT | Computed tomography |
| ELIC | Early Lung Imaging Confederation |
| EMA | European Medicines Agency |
| ESMO | European Society for Medical Oncology |
| FDA | Food and Drug Administration |
| HER2 | Human epidermal growth factor receptor 2 |
| IASLC | International Association for the Study of Lung Cancer |
| LLM | Large language models |
| MoDaC | NCI Predictive Oncology Model and Data Clearinghouse |
| MRI | Magnetic resonance imaging |
| NCCN | National Comprehensive Cancer Network |
| NCI | National Cancer Institute |
| NMR-QCS | Normalized membrane ratio-quantitative continuous scoring |
| NSCLC | Non-small cell lung cancer |
| PD-L1 | Programmed death-ligand 1 |
| PET | Positron emission tomography |
| RAG | Retrieval-augmented generation |
| ROC | Receiver operating characteristic |
| SHaP | SHapley Additive exPlanations |
| TCGA | The Cancer Genome Atlas |
| TPS | Tumor Proportion Score |
| TROP2 | Trophoblast cell surface antigen 2 |
| WHO | World Health Organization |